Thus, therapeutic vaccines can be considered for the treatment of HCC because about 80% of HCC patients express high levels of the alpha-fetoprotein (AFP), which can serve as a target for such immunotherapy [3,4]. Here, AFP is linked to hepatocellular carcinoma.